Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7550275 | 0.94 | EPHX1 (0.48) | EPHX1SMN1; SMN2LMNAHPGDALDH1A1 | |
| SCHEMBL7550564 | 0.93 | EPHX1 (0.52) | EPHX1SMN1; SMN2LMNAHPGDALDH1A1 | |
| SCHEMBL7550565 | 0.93 | EPHX1 (0.52) | EPHX1SMN1; SMN2LMNAHPGDALDH1A1 | |
| SCHEMBL7546089 | 0.93 | EPHX1 (0.52) | EPHX1SMN1; SMN2LMNAHPGDALDH1A1 | |
| SCHEMBL7544676 | 0.93 | EPHX1 (0.52) | EPHX1SMN1; SMN2LMNAHPGDALDH1A1 | |
| SCHEMBL7548924 | 0.93 | EPHX1 (0.52) | EPHX1SMN1; SMN2LMNAHPGDALDH1A1 | |
| SCHEMBL2669454 | 0.88 | MCL1 (0.53) | EPHX1SMN1; SMN2KDM4ELMNAHPGD | |
| SCHEMBL7543397 | 0.87 | ALDH1A1 (0.43) | SMN1; SMN2KDM4ELMNAACHEALDH1A1 | |
| SCHEMBL7545107 | 0.85 | EPHX2 (0.42) | LMNAACHEALDH1A1TSHRMGLL | |
| SCHEMBL7550207 | 0.84 | TSHR (0.40) | SMN1; SMN2KDM4ELMNAACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | disclosed |
| EP-0824316-A4 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 2001-01-17 | — | — | EP | disclosed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | disclosed |
| EP-0824316-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Nielsen, Thor, B. (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996034526-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 1996-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | EPHX1 2739/4885SMN1; SMN2 4736/4885KDM4E 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.